Selective effects of Adriamycin on murine host defense systems.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D002450:Cell Communication / Q000187:drug effects; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004317:Doxorubicin / Q000494:pharmacology*; D007111:Immunity, Cellular / Q000187:drug effects; D007113:Immunity, Innate / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008223:Lymphoma / Q000276:immunology; D008264:Macrophages / Q000187:drug effects; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D010587:Phagocytosis / Q000187:drug effects; D013154:Spleen / Q000187:drug effects; D013601:T-Lymphocytes / Q000187:drug effects
D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D004317:Doxorubicin